The promoter region of the human BUBR1 gene and its expression analysis in lung cancer

Lung Cancer

Volumn 38, Issue 3, 2002, Pages 229-234

  Seike, Masahiro ^a   Gemma, Akihiko ^a   Hosoya, Yoko ^a   Hosomi, Yukio ^a   Okano, Tetsuya ^a   Kurimoto, Futoshi ^a   Uematsu, Kazutsugu ^a   Takenaka, Kiyoshi ^a   Yoshimura, Akinobu ^a   Shibuya, Masahiko ^a   Ui Tei, Kumiko ^a   Kudoh, Shoji ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Expression; Genomic structure; Human BUBR1 gene; Lung cancer; Promoter region

Indexed keywords

MYOD PROTEIN; OCTAMER TRANSCRIPTION FACTOR 1; TESTIS DETERMINING FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AML; TRANSCRIPTION FACTOR CDXA; TRANSCRIPTION FACTOR HNF 3B; TRANSCRIPTION FACTOR IK 2; TRANSCRIPTION FACTOR NKX 2; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR STAF; TRANSCRIPTION FACTOR V MYB; UNCLASSIFIED DRUG; BUB1 SPINDLE CHECKPOINT PROTEIN; CELL CYCLE PROTEIN; PROTEIN KINASE;

ARTICLE; BUBR1 GENE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; DNA FLANKING REGION; EXON; GC RICH SEQUENCE; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; MITOSIS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN MOTIF; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MOLECULAR GENETICS; MUTATION;

CELL CYCLE PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS (GENETICS); PROTEIN KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0036890404     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00218-0     Document Type: Article

References (24)

1. Mitelman F., Johansson B., Mertens F. Catalog of chromosome aberrations in cancer. 2:1994;Wiley-Liss, New York.
2. Lengauer C., Kinzler K.W., Vogelstein B. Genetic instabilities in human cancers. Nature. 396:1998;643-649.
3. Elledge S.J. Cell cycle checkpoints: preventing an identity crisis. Science. 274:1996;1664-1672.
4. Murray A.W. The genetics of cell cycle checkpoints. Curr. Opin. Genet. Dev. 5:(5):1995;11.
5. Nasmyth K. At the heart of the budding yeast cell cycle. Trends Genet. 12:1996;405-412.
6. Paulovich A.G., Toczyski D.P., Hartwell L.H. When checkpoints fail. Cell. 88:1997;315-321.
7. Cahill D.P., Lengauer C., Yu J., et al. Mutations of mitotic checkpoint genes in human cancers. Nature. 392:1998;300-303.
8. Takahashi T., Haruki N., Nomoto S., et al. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers. Oncogene. 18:1999;4295-4300.
9. Gemma A., Seike M., Seike Y., et al. Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer. Genes Chromosomes Cancer. 29:2000;213-218.
10. Nomoto S., Haruki N., Takahashi T., et al. Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancers. Oncogene. 18:1999;7180-7183.
11. Li Y., Benezra R. Identification of a human mitotic checkpoint gene: hsMAD2. Science. 274:1996;246-248.
12. Jablonski S.A., Chan G.K., Cooke C.A., Earnshaw W.C., Yen T.J. The hBUB1 and hBUBR1 kinases sequentially assemble onto kinetochores during prophase with hBUBR1 concentrating at the kinetochore plates in mitosis. Chromosoma. 107:1998;386-396.
13. Chan G.K., Schaar B.T., Yen T.J. Characterization of the kinetochore binding domain of CENP-E reveals interactions with the kinetochore proteins CENP-F and hBUBR1. J. Cell Biol. 143:1998;49-63.
14. Chan G.K., Jablonski S.A., Sudakin V., Hittle J.C., Yen T.J. Human BUBR1 is a mitotic checkpoint kinase that monitors CENP-E functions at kinetochores and binds the cyclosome/APC. J. Cell Biol. 146:1999;941-954.
15. Yao X., Abrieu A., Zheng Y., Sullivan K.F., Cleveland D.W. CENP-E forms a link between attachment of spindle microtubules to kinetochores and the mitotic checkpoint. Nat. Cell Biol. 2:2000;484-491.
16. Futamura M., Arakawa H., Matsuda K., et al. Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1. Cancer Res. 60:2000;1531-1535.
17. Gemma A., Hagiwara K., Ke Y., et al. FHIT mutations in human primary gastric cancer. Cancer Res. 57:1997;1435-1437.
18. Gemma A., Takenaka K., Hosoya Y., et al. Altered expression of several genes in highly metastatic subpopulations of a human pulmonary adenocarcinoma cell line. Eur. J. Cancer. 37:(12):2001;1554-1561.
19. Gemma A., Hagiwara K., Vincent F., et al. hSmad5 gene, a human hSmad family member: its full length cDNA, genomic structure, promoter region and mutation analysis in human tumors. Oncogene. 16:1998;951-956.
20. Hagiwara K., Harris C.C. Long distance sequencer methods: a novel strategy for large DNA sequencing projects. Nucleic Acids Res. 24:1996;2460-2461.
21. Gemma A., Hosoya Y., Seike M., et al. Genomic structure of the human MAD2 gene in human breast and lung cancers. Lung Cancer. 32:(3):2001;289-295.
22. Ohshima K., Haraoka S., Yoshioka S., et al. Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma. Cancer Lett. 158:(2):2000;141-150.
23. Sato M., Sekido Y., Horio Y., et al. Infrequent mutation of the hBUB1 and hBUBR1 genes in human lung cancer. Jpn. J. Cancer Res. 91:2000;504-509.
24. Haruki N., Saito H., Harano T., et al. Molecular analysis of the mitotic checkpoint genes BUB1, BUBR1 and BUB3 in human lung cancers. Cancer Lett. 162:(2):2001;201-205.